In this retrospective study, intradermal test (IDT) results and the clinical efficacy of allergen-specific immunotherapy (ASIT) were evaluated in 84 horses diagnosed with equine asthma (EA), equine allergic skin disease (EASD), headshaking (HS), or combinations of these conditions. Inclusion was based on clinical diagnosis and suspicion of an IgE-mediated type I hypersensitivity component. IDT was performed using up to 23 selected allergen extracts based on clinical presentation. Insect allergens were the predominant sensitizers across all diagnostic groups. Mosquito allergens were positive in 77/84 horses, Culex in 72/84, Tabanus in 69/84, and Culicoides in 64/84. Environmental allergens such as dog epithelium (54/78 tested horses) and house dust mites (Dermatophagoides farinae 45/84; Tyrophagus putrescentiae 44/84) were also frequently identified. Relevant sensitization patterns were observed not only in EASD but also in EA and HS cases. ASIT was considered indicated in 55 horses based on clinical–allergological correlation; 52 horses were subsequently treated. Follow-up after at least eight months was available for 32 horses. Good to excellent clinical improvement was reported in 6/8 EA horses, 7/8 EASD horses, all 7 EA+EASD horses, and 2/3 HS horses. No serious adverse reactions were observed. The results support IDT-guided ASIT as a safe adjunctive therapy in horses with chronic allergic disease. Insect allergens appear to play a central role across different clinical presentations. IDT and ASIT may also represent useful diagnostic and therapeutic tools in selected horses with EA and HS.
Keywords: Horse; Intradermal Test; Allergen-Specific Immunotherapy; Equine Asthma; Equine Allergic Skin Disease; Headshaking; Insect Allergens
Keywords: horses, chronic recurrent cecal impaction, surgical treatment enlargement cecocolic orifice, long-term survival